Novo Nordisk said its Wegovy injectable drug for weight loss now has more than 130,000 weekly prescriptions in North America alone after boosting supplies to meet insatiable demand.
Novo Nordisk now has more than 130,000 weight-loss prescriptions as it hikes financial outlook
